|
[1]
|
Inhibition ofATPsynthase reverse activity restores energy homeostasis in mitochondrial pathologies
The EMBO Journal,
2023
DOI:10.15252/embj.2022111699
|
|
|
|
|
[2]
|
Taurine and the Mitochondrion: Applications in the Pharmacotherapy of Human Diseases
2023
DOI:10.2174/9789815124484123010009
|
|
|
|
|
[3]
|
The Role of Taurine in Skeletal Muscle Functioning and Its Potential as a Supportive Treatment for Duchenne Muscular Dystrophy
Metabolites,
2022
DOI:10.3390/metabo12020193
|
|
|
|
|
[4]
|
Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts
eLife,
2022
DOI:10.7554/eLife.75521
|
|
|
|
|
[5]
|
Les maladies mitochondriales de l’adulte : mise au point
La Revue de Médecine Interne,
2021
DOI:10.1016/j.revmed.2020.12.002
|
|
|
|
|
[6]
|
Les maladies mitochondriales de l’adulte : mise au point
La Revue de Médecine Interne,
2021
DOI:10.1016/j.revmed.2020.12.002
|
|
|
|
|
[7]
|
β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy
Nutrients,
2021
DOI:10.3390/nu13051619
|
|
|
|
|
[8]
|
β-Glucans as Dietary Supplement to Improve Locomotion and Mitochondrial Respiration in a Model of Duchenne Muscular Dystrophy
Nutrients,
2021
DOI:10.3390/nu13051619
|
|
|
|
|
[9]
|
Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice
Scientific Reports,
2019
DOI:10.1038/s41598-019-38609-4
|
|
|
|
|
[10]
|
Crosstalk between Calcium and ROS in Pathophysiological Conditions
Oxidative Medicine and Cellular Longevity,
2019
DOI:10.1155/2019/9324018
|
|
|
|
|
[11]
|
Mitochondrial dysfunction causes Ca2+ overload and ECM degradation–mediated muscle damage in C. elegans
The FASEB Journal,
2019
DOI:10.1096/fj.201802298R
|
|
|
|
|
[12]
|
Mitochondria-Targeted Drugs
Current Molecular Pharmacology,
2019
DOI:10.2174/1874467212666181127151059
|
|
|
|
|
[13]
|
Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice
Scientific Reports,
2019
DOI:10.1038/s41598-019-38609-4
|
|
|
|
|
[14]
|
Reduced mitochondrial respiration and increased calcium deposits in the EDL muscle, but not in soleus, from 12-week-old dystrophic mdx mice
Scientific Reports,
2019
DOI:10.1038/s41598-019-38609-4
|
|
|
|
|
[15]
|
IP3 receptor blockade restores autophagy and mitochondrial function in skeletal muscle fibers of dystrophic mice
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
2018
DOI:10.1016/j.bbadis.2018.08.042
|
|
|
|
|
[16]
|
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Advanced Drug Delivery Reviews,
2016
DOI:10.1016/j.addr.2015.12.024
|
|
|
|
|
[17]
|
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Advanced Drug Delivery Reviews,
2016
DOI:10.1016/j.addr.2015.12.024
|
|
|
|
|
[18]
|
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Advanced Drug Delivery Reviews,
2016
DOI:10.1016/j.addr.2015.12.024
|
|
|
|
|
[19]
|
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
Advanced Drug Delivery Reviews,
2016
DOI:10.1016/j.addr.2015.12.024
|
|
|
|
|
[20]
|
Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy
Expert Opinion on Orphan Drugs,
2016
DOI:10.1080/21678707.2016.1240613
|
|
|
|